These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17626040)

  • 21. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.
    Cats EA; van der Pol WL; Piepers S; Franssen H; Jacobs BC; van den Berg-Vos RM; Kuks JB; van Doorn PA; van Engelen BG; Verschuuren JJ; Wokke JH; Veldink JH; van den Berg LH
    Neurology; 2010 Aug; 75(9):818-25. PubMed ID: 20805527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.
    Eftimov F; Vermeulen M; de Haan RJ; van den Berg LH; van Schaik IN
    J Peripher Nerv Syst; 2009 Jun; 14(2):93-100. PubMed ID: 19691531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study.
    Lambrecq V; Krim E; Rouanet-Larrivière M; Lagueny A
    Muscle Nerve; 2009 Feb; 39(2):131-6. PubMed ID: 19127532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of multifocal motor neuropathy.
    Nobile-Orazio E; Terenghi F; Carpo M; Bersano A
    Neurol Sci; 2003 Oct; 24 Suppl 4():S251-5. PubMed ID: 14598054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD003217. PubMed ID: 22513910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal motor neuropathy.
    Van Asseldonk JT; Franssen H; Van den Berg-Vos RM; Wokke JH; Van den Berg LH
    Lancet Neurol; 2005 May; 4(5):309-19. PubMed ID: 15847844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.
    Vucic S; Black KR; Chong PS; Cros D
    Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy.
    Comi G; Amadio S; Galardi G; Fazio R; Nemni R
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):35-7. PubMed ID: 7964850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.
    Majithia V; Harisdangkul V
    Rheumatology (Oxford); 2005 Mar; 44(3):386-9. PubMed ID: 15572389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifocal motor neuropathy.
    Nobile-Orazio E
    J Neuroimmunol; 2001 Apr; 115(1-2):4-18. PubMed ID: 11282149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of mycophenolate mofetil for treatment of kidney disease due to congenital urinary tract disorders in children.
    Trachtman H; Christen E; Frank R; Rini J; Palestro C; Perelstein E; Weiss L; Tarapore F; Fortune S; Horowitz J
    Am J Kidney Dis; 2008 Oct; 52(4):706-15. PubMed ID: 18554762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMN: from immunological cross-talk to conduction block.
    Harschnitz O; Jongbloed BA; Franssen H; Straver DC; van der Pol WL; van den Berg LH
    J Clin Immunol; 2014 Jul; 34 Suppl 1(Suppl 1):S112-9. PubMed ID: 24728842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab].
    Michaud A; Delmont E; Jeandel PY; Desnuelle C
    Rev Neurol (Paris); 2011 Dec; 167(12):916-20. PubMed ID: 21752414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and functional change in multifocal motor neuropathy treated with IVIg.
    Chia PK; Hung SKY; Hiew FL
    J Clin Neurosci; 2019 Nov; 69():114-119. PubMed ID: 31416736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.
    Federico P; Zochodne DW; Hahn AF; Brown WF; Feasby TE
    Neurology; 2000 Nov; 55(9):1256-62. PubMed ID: 11087764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.